Vasoactive and permeability effects of vascular endothelial growth factor-165 in the term in vitro dually perfused human placental lobule

Endocrinology

Volumn 148, Issue 10, 2007, Pages 4734-4744

  Brownbill, P ^a,d   McKeeman, G C ^b   Brockelsby, J C ^c   Crocker, I P ^a   Sibley, C P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c Rosie Maternity Hospital   (United Kingdom)

^d ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; NITRIC OXIDE; PROSTACYCLIN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 121; VASCULOTROPIN 145; VASCULOTROPIN 165; VASCULOTROPIN RECEPTOR 1;

ARTICLE; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FETOPLACENTAL UNIT; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PLACENTA; PLACENTA WEIGHT; PRIORITY JOURNAL; SECOND MESSENGER; STATISTICAL ANALYSIS; VASOCONSTRICTION; VASODILATATION; WESTERN BLOTTING;

ANIMALS; BLOOD VESSELS; CELL MEMBRANE PERMEABILITY; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; FEMALE; HUMANS; NITRIC OXIDE; PEPTIDE FRAGMENTS; PERFUSION; PERMEABILITY; PLACENTA; PREGNANCY; PROTEIN ISOFORMS; RECOMBINANT PROTEINS; SECOND MESSENGER SYSTEMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASODILATION;

EID: 34748817384     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0180     Document Type: Article

References (68)

1. Ferrara N, Henzel WJ 1989 Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-858
2. Ku DD, Zaleski JK, Liu S, Brock TA 1993 Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 265:H586-H592
3. Hariawala MD, Horowitz JR, Esakof D, Sheriff DD, Walter DH, Keyt B, Isner JM, Symes JF 1996 VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res 63:77-82
4. Ni Y, May V, Braas K, Osol G 1997 Pregnancy augments uteroplacental vascular endothelial growth factor gene expression and vasodilator effects. Am J Physiol 273:H938-H944
5. Liu MH, Jin HK, Floten HS, Yang Q, Yim AP, Furnary A, Zioncheck TF, Bunting S, He GW 2001 Vascular endothelial growth factor-mediated endothelium-dependent relaxation is blunted in spontaneously hypertensive rats. J Pharmacol Exp Ther 296:473-477
6. Itoh S, Brawley L, Wheeler T, Anthony FW, Poston L, Hanson MA 2002 Vasodilation to vascular endothelial growth factor in the uterine artery of the pregnant rat is blunted by low dietary protein intake. Pediatr Res 51:485-491
7. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA 2003 Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649-658
8. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J 1989 Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84:1470-1478
9. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF 1983 Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985
10. Kliche S, Waltenberger J 2001 VEGF receptor signaling and endothelial function. IUBMB Life 52:61-66
11. Charnock-Jones DS, Sharkey AM, Boocock CA, Ahmed A, Plevin R, Ferrara N, Smith SK 1994 Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol Reprod 51:524-530
12. Bates DO, Hillman NJ, Williams B, Neal CR, Pocock TM 2002 Regulation of microvascular permeability by vascular endothelial growth factors. J Anat 200:581-597
13. Poltorak Z, Cohen T, Sivan R, Kandelis Y, Spira G, Vlodavsky I, Keshet E, Neufeld G 1997 VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem 272:7151-7158
14. Ahmed A, Li XF, Dunk C, Whittle MJ, Rushton DI, Rollason T 1995 Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors 12:235-243
15. Anthony FW, Wheeler T, Elcock CL, Pickett M, Thomas EJ 1994 Short report: identification of a specific pattern of vascular endothelial growth factor mRNA expression in human placenta and cultured placental fibroblasts. Placenta 15:557-561
16. Lash GE, Taylor CM, Trew AJ, Cooper S, Anthony FW, Wheeler T, Baker PN 2002 Vascular endothelial growth factor and placental growth factor release in cultured trophoblast cells under different oxygen tensions. Growth Factors 20:189-196
17. Hoffmann P, Feige JJ, Alfaidy N 2006 Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy. Endocrinology 147:1675-1684
18. Cheung CY, Singh M, Ebaugh MJ, Brace RA 1995 Vascular endothelial growth factor gene expression in ovine placenta and fetal membranes. Am J Obstet Gynecol 173:753-759
19. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z 1999 Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9-22
20. Zachary I, Gliki G 2001 Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 49:568-581
21. Clark DE, Smith SK, Sharkey AM, Charnock-Jones DS 1996 Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy. Hum Reprod 11:1090-1098
22. Gerber HP, Condorelli F, Park J, Ferrara N 1997 Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 272:23659-23667
23. Chung JY, Song Y, Wang Y, Magness RR, Zheng J 2004 Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and pre-eclamptic pregnancies. J Clin Endocrinol Metab 89:2484-2490
24. Esser S, Lampugnani MG, Corada M, Dejana E, Risau W 1998 Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci 111(Pt 13):1853-1865
25. Helske S, Vuorela P, Carpen O, Hornig C, Weich H, Halmesmaki E 2001 Expression of vascular endothelial growth factor receptors 1,2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod 17:205-210
26. Kendall RL, Wang G, Thomas KA 1996 Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 226:324-328
27. Ahmad S, Ahmed A 2004 Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 95:884-891
28. Poston L 1997 The control of blood flow to the placenta. Exp Physiol 82:377-87
29. Gude NM, King RG, Brennecke SP 1990 Role of endothelium-derived nitric oxide in maintenance of low fetal vascular resistance in placenta. Lancet 336:1589-1590
30. Myatt L, Brewer A, Brockman DE 1991 The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol 164:687-692
31. Brownbill P, Bell NJ, Woods RJ, Lowry PJ, Page NM, Sibley CP 2003 Neurokinin B is a paracrine vasodilator in the human fetal placental circulation. J Clin Endocrinol Metab 88:2164-2170
32. Brownbill P, Sibley CP 2006 Regulation of transplacental water transfer: the role of fetoplacental venous tone. Placenta 27:560-567
33. Schneider H, Panigel M, Dancis J 1972 Transfer across the perfused human placenta of antipyrine, sodium and leucine. Am J Obstet Gynecol 114:822-828
34. Edwards D, Jones CJ, Sibley CP, Nelson DM 1993 Paracellular permeability pathways in the human placenta: a quantitative and morphological study of maternal-fetal transfer of horseradish peroxidase. Placenta 14:63-73
35. Brownbill P, Edwards D, Jones C, Mahendran D, Owen D, Sibley C, Johnson R, Swanson P, Nelson DM 1995 Mechanisms of α-fetoprotein transfer in the perfused human placental cotyledon from uncomplicated pregnancy. J Clin Invest 96:2220-2226
36. Boito S, Struijk PC, Ursem NT, Stijnen T, Wladimiroff JW 2002 Umbilical venous volume flow in the normally developing and growth-restricted human fetus. Ultrasound Obstet Gynecol 19:344-349
37. McClure Browne JCVN 1953 The maternal placental blood flow in normatensive and hypertensive women. J Obstet Gynaecol Br Commonw 60:140-147
38. Anthony FW, Evans PW, Wheeler T, Wood PJ 1997 Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann Clin Biochem 34(Pt 3):276-280
39. Janvier A, Nadeau S, Baribeau J, Perreault T 2005 Role of vascular endothelial growth factor receptor 1 and vascular endothelial growth factor receptor 2 in the vasodilator response to vascular endothelial growth factor in the neonatal piglet lung. Crit Care Med 33:860-866
40. Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D, Kroll J, Plaisance S, De Mol M, Bono F, Kliche S, Fellbrich G, Ballmer-Hofer K, Maglione D, Mayr-Beyrle U, Dewerchin M, Dombrowski S, Stanimirovic D, Van Hummelen P, Dehio C, Hicklin DJ, Persico G, Herbert JM, Shibuya M, Collen D, Conway EM, Carmeliet P 2003 Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 9:936-943
41. Park JE, Chen HH, Winer J, Houck KA, Ferrara N 1994 Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 269:25646-25654
42. Shibuya M 2003 Vascular endothelial growth factor receptor-2: its unique signaling and specific ligand, VEGF-E. Cancer Sci 94:751-756
43. He H, Venema VJ, Gu X, Venema RC, Marrero MB, Caldwell RB 1999 Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem 274:25130-25135
44. Eliceiri BP, Puente XS, Hood JD, Stupack DG, Schlaepfer DD, Huang XZ, Sheppard D, Cheresh DA 2002 Src-mediated coupling of focal adhesion kinase to integrin α(v)β5 in vascular endothelial growth factor signaling. J Cell Biol 157:149-160
45. Brownbill P, Mahendran D, Owen D, Swanson P, Thornburg KL, Nelson DM, Sibley CP 2000 Denudations as paracellular routes for α-fetoprotein and creatinine across the human syncytiotrophoblast. Am J Physiol Regul Integr Comp Physiol 278:R677-R683
46. Bowers LD, Wong ET 1980 Kinetic serum creatinine assays. II. An initial evaluation and review. Clin Chem 26:255-261
47. Childs RE, Bardsley WG 1975 The steady state kinetics of peroxidase with 2,2′-azino-di-(3-ethyl-benzylthiazoline-6-sulphonic acid) as chromogen. Biochem J 145:93-103
48. Sibley CP, Boyd RDH 1988 Control of transfer across the mature placenta. In: Clarke JR, ed. Oxford reviews of reproductive biology. Oxford, UK: Oxford University Press; 382-435
49. Gitay-Goren H, Cohen T, Tessler S, Soker S, Gengrinovitch S, Rockwell P, Klagsbrun M, Levi BZ, Neufeld G 1996 Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells. J Biol Chem 271:5519-5523
50. Terman B, Khandke L, Dougher-Vermazan M, Maglione D, Lassam NJ, Gospodarowicz D, Persico MG, Bohlen P, Eisinger M 1994 VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor. Growth Factors 11:187-195
51. Bujold E, Romero R, Chaiworapongsa T, Kim YM, Kim GJ, Kim MR, Espinoza J, Goncalves LF, Edwin S, Mazor M 2005 Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin. J Matern Fetal Neonatal Med 18:9-16
52. He Y, Smith SK, Day KA, Clark DE, Licence DR, Charnock-Jones DS 1999 Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocrinol 13:537-545
53. Challier JC, Schneider H, Dancis J 1976 In vitro perfusion of human placenta. V. Oxygen consumption. Am J Obstet Gynecol 126:261-265
54. Hauguel S, Challier JC, Cedard L, Olive G 1983 Metabolism of the human placenta perfused in vitro: glucose transfer and utilization, O2 consumption, lactate and ammonia production. Pediatr Res 17:729-732
55. Claffey KP, Shih SC, Mullen A, Dziennis S, Cusick JL, Abrams KR, Lee SW, Detmar M 1998 Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability. Mol Biol Cell 9:469-481
56. Dulak J, Jozkowicz A 2003 Regulation of vascular endothelial growth factor synthesis by nitric oxide: facts and controversies. Antioxid Redox Signal 5:123-132
57. Baker PN, Krasnow J, Roberts JM, Yeo KT 1995 Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol 86:815-821
58. Lyall F, Young A, Boswell F, Kingdom JC, Greer IA 1997 Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta 18:269-276
59. Ebos JM, Bocci G, Man S, Thorpe PE, Hicklin DJ, Zhou D, Jia X, Kerbel RS 2004 A naturally occurring soluble form of vascular endothelial growth receptor 2 detected in mouse and human plasma. Mol Cancer Res 2:315-326
60. Szukiewicz D, Szewczyk G, Watroba M, Kurowska E, Maslinski S 2005 Isolated placental vessel response to vascular endothelial growth factor and placenta growth factor in normal and growth-restricted pregnancy. Gynecol Obstet Invest 59:102-107
61. Bird IM, Sullivan JA, Di T, Cale JM, Zhang L, Zheng J, Magness RR 2000 Pregnancy-dependent changes in cell signalling underlie changes in differential control of vasodilator production in uterine artery endothelial cells. Endocrinology 141:1107-1117
62. Korkmaz B, Ozveren E, Buharalioglu CK, Tunctan B 2006 Extracellular signal-regulated kinase (ERK1/2) contributes to endotoxin-induced hyporeactivity via nitric oxide and prostacyclin production in rat aorta. Pharmacology 78:123-128
63. Syeda F, Grosjean J, Houliston RA, Keogh RJ, Carter TD, Palelog E, Wheeler-Jones C 2006 Cyclooxegenase-2 induction and prostacyclin release by protease-activated receptors in endothelial cells require cooperation between mitogen-activated protein kinase and NF-κB pathways. J Biol Chem 281:11792-11804
64. Merhi-Soussi F, Dominguez Z, Macovschi O, Dubois M, Nemoz G, Lagarde M, Prigent A-F 2003 Mechanisms involved in the stimulation of prostacyclin synthesis by human lymphocytes in human umbilical vein endothelial cells. Br J Pharmacol 139:321-328
65. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC 1999 Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597-601
66. Rahimi N 2006 VEGFR-1 and VEGFR-2: two nonidentical twins with unique physiognomy. Front Biosci 11:818-829
67. Jauniaux E, Watson A, Burton G 2001 Evaluation of respiratory gases and acid-base gradients in human fetal fluids and uteroplacental tissue between 7 and 16 weeks' gestation. Am J Obstet Gynecol 184:998-1003
68. 2 and haematocrit following caesarean section before labour. Biol Neonate 63:147-152